Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute herpes zoster pain is very severe . Conventional analgesics may be of no value. Regional blocks may play a role
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | No Intervention | 800 mg acyclovir, 5 times / day, orally administered, for one week, acetaminophen 1000 mg per day, topical calamine lotion) | |
| Erector spinae group | Active Comparator | 800 mg acyclovir, 5 times / day, orally administered, for one week, acetaminophen 1000 mg per day, topical calamine lotion)+ 25 ml bupivacaine 0.25% plus 8 mg dexamethasone |
|
| Serratus anterior group | Active Comparator | 800 mg acyclovir, 5 times / day, orally administered, for one week, acetaminophen 1000 mg per day, topical calamine lotion)+ 25 ml bupivacaine 0.25% plus 8 mg dexamethasone |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ultrasound guided erector spine block | Procedure | Ultrasound guided thoracic erector spinae block |
|
| Measure | Description | Time Frame |
|---|---|---|
| pain score | Visual analogue scale from 0 to 10. 0= NO pain, 1-3=mild tolerable pain, 4-6= moderate pain, 7-10= severe untearable pain. | immediate after injection, 1 week, 1, 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients with pain recurrence | Number of patients in need for re-injection | 1 week, 1, and 3 months |
| analgesic consumption | total amount dose of analgesics used |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Serratus anterior block | Procedure | Ultrasound guided serratus anterior block |
|
| 1 week, 1, and 3 months |
| Incidence of treatment related adverse events | hypotension, bradyarrhythmia, hematoma | immediately after injection |